GSA Capital Partners’s Instil Bio TIL Stock Holding History

GSA Capital Partners’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,241	Closed	-$113K	–	1900
2023 Q2	$113K	Buy	+10,241	New	+$125K	0.01%	1368
2023 Q1	–	Sell	-822	Closed	-$10K	–	1935
2022 Q4	$10K	Buy	+822	New	+$40.6K	﹤0.01%	1393
2022 Q3	–	Sell	-775	Closed	-$72K	–	1858
2022 Q2	$72K	Buy	+775	New	+$110K	0.01%	1259

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GSA Capital Partners's TIL Position: Q3 2023 in Review

GSA Capital Partners sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 10,241 shares — an estimated $113K sold.

GSA Capital Partners first reported a position in TIL in Q2 2022 and held it in 3 quarters. The position peaked at $113K in Q2 2023. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

GSA Capital Partners reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
GSA Capital Partners sold 10,241 Instil Bio shares in Q3 2023, an estimated $113K.
GSA Capital Partners first reported a position in Instil Bio in Q2 2022 and held it in 3 quarters.
GSA Capital Partners's Instil Bio position peaked at $113K in Q2 2023.
58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.